Post-Traumatic Stress Disorder - 331-201-00071 (Otsuka)

Clinical trial to examine the efficacy and safety of brexpriprazole combined with sertraline as treatment for adults with posttraumatic stress disorder.

Qualified participants include:

  • Adults aged 18 to 65 years old
  • Have been diagnosed with posttraumatic stress disorder
  • Onset of symptoms for a minimum of 6 months prior to screening

Those that qualify will:

  • Receive study drug and study-related care with a board-certified psychiatrist and other clinical staff at no cost.
  • Receive reimbursement for study participation and costs.

Contact Clinical Trials at 860.545.7476 or via email

Join our Research Registry

If you are interested in participating in research at the Clinical Trials Unit follow the link below to sign up for our research registry. This will allow us to contact you for current and future research opportunities at the CTU. If you have any questions, please email
 or call 860.545.7476.

Click here to join